The reaction of N -pentyl-4-methylpyridinium bromide with Na[7,8-bis(dicyclohexylphosphino)-7,8-dicarba- nido -C 2 B 9 H 10 ] led to the formation of a pyridinium salt of the carboranyldiphosphine ligand, [ N -pentyl-4-methylpyridinium] + [7,8-bis(dicyclohexylphosphino)-7,8-dicarba- nido -C 2 B 9 H 10 ] − ( 1 ), in 86% yield. [7,8-bis(dicyclohexylphosphino)-7,8-dicarba- nido -C 2 B 9 H 10 ] − was produced in situ from the decapitation of 1,2-bis(dicyclohexylphosphino)-1,2-dicarba- closo -dodecaborane with sodium hydroxide. Ligand 1 is highly soluble in ionic liquids such as trihexyltetradecylphosphonium dodecylbenzene sulfonate ([THTdP][DBS]) and 1-hexyl-3-methylimidazolium trifluoromethansulfonate ([HMIM][CF 3 SO 3 ]) and was used as a bulky catalyst composite with the ionic liquids [THTdP][DBS] and [HMIM][CF 3 SO 3 ], with stabilized iridium(0) nanoparticles produced by thermolysis of Ir 4 (CO) 12, or with the iridium complex [Ir(coe) 2 Cl] 2 (coe = cyclooctene) and in the ionic liquid [THTdP][DBS] and [HMIM][CF 3 SO 3 ] for the hydroboration of methyl oleate (MO), methyl 10-undecenoate, and 1-hexene. The new Ir(0) catalytic system was found to be efficient, robust, and recyclable so that a number of repetitious hydroborations of MO with high product selectivity could be accomplished.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: